Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company reported a revenue of 895 million yuan for the first half of 2025, representing a year-on-year increase of 20.31%, while the net profit attributable to the parent company was 188 million yuan, up 4.16% year-on-year [2] - The second quarter of 2025 saw a revenue of 655 million yuan, a year-on-year increase of 13.46%, but the net profit decreased by 0.85% year-on-year, indicating pressure on profitability due to declining gross profit and increased sales expenses [2][4] - The company plans to distribute a mid-term dividend of 2.00 yuan per 10 shares, totaling 80.92 million yuan [2] Revenue Analysis - The slowdown in revenue growth in Q2 is attributed to high base effects, adverse weather conditions, and intensified competition [3] - The company’s product categories showed varied performance, with mosquito repellent and baby care products achieving revenue of 375 million yuan and 405 million yuan respectively, while essential oils saw a decline of 14.60% [3] - The company launched over 40 new products during the reporting period, including sunscreen and youth series products, which are expected to drive growth in the second half of the year [3] Profitability Analysis - The company's gross margin and net margin for the first half of 2025 were 58.01% and 20.95%, respectively, showing a decline compared to the previous year [4] - The increase in expense ratios, particularly in sales and financial expenses, has pressured profitability, with the sales expense ratio rising to 29.81% in Q2 [4] Investment Recommendations - The company has a strong competitive position in the baby care and mosquito repellent market, with a solid brand image and ongoing product development [5] - Despite short-term pressures, the long-term growth logic remains intact, with revised revenue forecasts for 2025-2027 at 1.616 billion, 2.054 billion, and 2.609 billion yuan respectively [5] - The expected earnings per share for 2025-2027 are 0.83, 1.06, and 1.37 yuan, with corresponding price-to-earnings ratios of 39, 30, and 23 times [5]
润本股份(603193):Q2阶段性承压,中长期逻辑不变